CFTR and cystic fibrosis: The bronchial epithelial cell line CFBE41o- was derived from a CF patient carrying a homozygous ΔF508 mutation, and hence seems a suitable in vitro model for evaluating small molecule compounds or gene editing approaches for their ability to restore CFTR function [34,35].